Paul Thoueille

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


16 publications

Sous presse
 
Is Non-Sustained Viral Suppression with Long-Acting Cabotegravir and Rilpivirine Really Independent of Drug levels?
Thoueille P., Marzolini C., Guidi M., Cavassini M., Decosterd L.A. Clinical infectious diseases. Peer-reviewed.
[DOI][Pmid][serval:BIB_3FF55B9C536F]
2024
 
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
Sáez-Cirión A., Mamez A.C., Avettand-Fenoel V., Nabergoj M., Passaes C., Thoueille P., Decosterd L., Hentzien M., Perdomo-Celis F., Salgado M. et al., 2024/12. Nature medicine, 30 (12) pp. 3544-3554. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2BCEBE82B4CC]
 
Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations.
Bongiovanni M., Thoueille P., Barda B., Mercier T., Marzolini C., Ramponi N., Choong E., Cantù M., Decosterd L.A., Bernasconi E., 2024/07. European journal of clinical microbiology & infectious diseases, 43 (7) pp. 1503-1504. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_798E811CC577]
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV.
Thoueille P., Saldanha S.A., Schaller F., Choong E., Veuve F., Munting A., Cavassini M., Braun D., Günthard H.F., Duran Ramirez J.J. et al., 2024/06. Clinical pharmacology and therapeutics, 115 (6) pp. 1450-1459. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A008171B295E]
Population pharmacokinetic analysis of doravirine in real-world people with HIV.
Thoueille P., Delarive L., Cavassini M., Buclin T., Decosterd L.A., Marzolini C., Girardin F.R., Guidi M., Swiss HIV Cohort Study, 2024/04. British journal of clinical pharmacology, 90 (4) pp. 1058-1065. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0E37EFB8FE58]
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Thoueille P., Cavassini M., Guidi M., Buclin T., Girardin F.R., Decosterd L.A., Marzolini C., 2024/02. Open forum infectious diseases, 11 (2) pp. ofae023. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E70DD8E56C37]
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV.
Thoueille P., Saldanha S.A., Schaller F., Choong E., Veuve F., Munting A., Cavassini M., Braun D., Günthard H.F., Duran Ramirez J.J. et al., 2024. Frontiers in pharmacology, 15 p. 1437400. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9DDB05C5BD5C]
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P., Saldanha S.A., Schaller F., Choong E., Munting A., Cavassini M., Braun D., Günthard H.F., Kusejko K., Surial B. et al., 2024/01. The Lancet regional health. Europe, 36 p. 100793. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EE4919775F0F]
2023
Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-study.
Thoueille P., Delfraysse M., Andre P., Buclin T., Decosterd L.A., Fedeli C., Ustero P., Calmy A., Guidi M., Swiss HIV Cohort Study, 2023/09/27. BMC pharmacology & toxicology, 24 (1) p. 47. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0252DE874823]
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration.
Thoueille P., Alves Saldanha S., Desfontaine V., Kusejko K., Courlet P., Andre P., Cavassini M., Decosterd L.A., Buclin T., Guidi M. et al., 2023/06/01. The Journal of antimicrobial chemotherapy, 78 (6) pp. 1433-1443. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_449BF24E5A20]
 
Utilité du TDM des anti-rétroviraux: passé, présent, futur
Choong Eva, Thoueille Paul, Cavassini M., Decosterd Laurent, 2023/05/04. dans Association pour la ormation en Analyses de Biologie Spécialisée (AFABS) - Journée de formation du 4 mai 2023 - Lausanne . Peer-reviewed.
[serval:BIB_D453D7DC90C4]
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies.
Biniecka P., Matsumoto S., Belotti A., Joussot J., Bai J.F., Majjigapu S.R., Thoueille P., Spaggiari D., Desfontaine V., Piacente F. et al., 2023/02/16. Molecules, 28 (4) p. 1897. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9D877CB69A0A]
Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the monitoring of temsavir plasma concentrations in people living with HIV.
Thoueille P., Seybold U., Decosterd L.A., Desfontaine V., 2023/01/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1214 p. 123575. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0B73DC88085D]
2022
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
Thoueille P., Alves Saldanha S., Schaller F., Munting A., Cavassini M., Braun D., Günthard H.F., Kusejko K., Surial B., Furrer H. et al., 2022/07/29. Pharmaceutics, 14 (8) p. 1588. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EA4A25E4F31E]
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection.
Thoueille P., Choong E., Cavassini M., Buclin T., Decosterd L.A., 2022/02/02. The Journal of antimicrobial chemotherapy, 77 (2) pp. 290-302. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C31B6241296B]
2020
Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers.
Dao K., Thoueille P., Decosterd L.A., Mercier T., Guidi M., Bardinet C., Lebon S., Choong E., Castang A., Guittet C. et al., 2020/02. Pharmacology research & perspectives, 8 (1) pp. e00558. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0D0F21F7F1EC]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University